-
1.发明公开
公开(公告)号：EP3347022A1
公开(公告)日：2018-07-18
申请号：EP16844729.0
申请日：2016-09-09
申请人： Yuyu Pharma, Inc.
发明人： BAIK, Taegon , KIM, Seyeon , AHN, Kyeongjin , KIM, Ju-hee , PARK, Young-joon
CPC分类号： A61K31/58 , A61K9/4866
摘要： The present disclosure relates to a pharmaceutical composition comprising dutasteride and propylene glycol monolaurate, and a capsule formulation comprising the same.
-
公开(公告)号：EP4114430A2
公开(公告)日：2023-01-11
申请号：EP21774671.8
申请日：2021-03-05
申请人： YUYU Pharma, Inc.
发明人： YU, Wonsang , PARK, Larry, Chong
-
3.发明公开
公开(公告)号：EP1984370A1
公开(公告)日：2008-10-29
申请号：EP07701041.1
申请日：2007-01-23
发明人： LEE, Seung Chul , CHOI, Jin Seok , OH, Jung Hoon , PARK, Boonsaeng , KIM, Yong Eun , LEE, Jun Hee , SHIN, Dongkyu , KIM, Cheol Min , HYUN, Young-Lan , LEE, Cheol Soon , CHO, Joong-Myung , RO, Seonggu
IPC分类号： C07D487/04
CPC分类号： C07D471/04
摘要： The inventive imidazopyridine derivative can be used in a pharmaceutical composition for preventing or treating diseases such as diabetes, obesity, dementia, cancer, and inflammation, since it can efficiently inhibit the activities of several protein kinases including glycogen synthase kinase-3 (GSK-3), aurora kinase, extracellular signal-regulated kinase (ERK), protein kinase B (AKT), and the likes, to control signal transductions thereof.
-
公开(公告)号：EP3880690A2
公开(公告)日：2021-09-22
申请号：EP19883897.1
申请日：2019-11-14
申请人： YUYU Pharma, Inc.
发明人： BAIK, Taegon , CHOI, Jong-Yun , MIN, Gyoung-Wook , PARK, Chun Ho
-
公开(公告)号：EP3454840A1
公开(公告)日：2019-03-20
申请号：EP17796448.3
申请日：2017-05-12
申请人： Yuyu Pharma, Inc.
发明人： BAIK, Taegon , KIM, Seyeon , KIM, Ju-hee , SONG, Seung Han , PARK, Young-joon
-
6.发明授权PHARMACEUTICAL COMPOSITIONS AND PREPARATIONS FOR TREATMENT OF METABOLIC BONE DISEASE 有权药物组合物和代谢性骨疾病的治疗引起的筹备工作
公开(公告)号：EP1229917B1
公开(公告)日：2008-12-17
申请号：EP00971847.9
申请日：2000-10-20
申请人： YUYU Pharma, Inc.
CPC分类号： A61K31/66 , A61K9/1623 , A61K9/2077 , A61K9/2866 , A61K9/4858 , A61K9/5084 , A61K31/59 , A61K2300/00
摘要： The present invention relates to a pharmaceutical composition for the treatment of metabolic bone disease and the method of preparation thereof, and more particularly, to an improved pharmaceutical composition for the therapeutic treatment of metabolic disease and the method of preparation thereof, wherein said composition is prepared as a composite pharmaceutical agent which comprises calcitriol; which reduces the rate of spine fractures and increases bone density; alendronate, a bone resorption inhibitor, as two main active ingredients in an optimal mixing ratio to exert the greatest synergistic therapeutic effect; and adequate amount of other additives such as a resorption fortifier of alendronate. Therefore, the pharmaceutical composition according to the present invention can inhibit hypercalcemia caused when administered by calcitriol alone, compensate the inhibitory activity of bone remodeling caused by alendronate due to the presence of calcitriol, and improve drug compliance associated with the usual difficulty in administration as well as a side effect in esophagus, thus effectively preventing the occurence of osteoporosis.
-
公开(公告)号：EP3518906A1
公开(公告)日：2019-08-07
申请号：EP17856717.8
申请日：2017-09-27
申请人： Yuyu Pharma, Inc.
发明人： BAIK, Taegon , KIM, Seyeon , KIM, Ju-hee , SONG, Seung Han , PARK, Young-joon , PARK, Kyung Mi
IPC分类号： A61K9/48 , A61K31/58 , A61K31/4985
-
8.发明公开
公开(公告)号：EP1984370A4
公开(公告)日：2010-03-31
申请号：EP07701041
申请日：2007-01-23
发明人： LEE SEUNG CHUL , CHOI JIN SEOK , OH JUNG HOON , PARK BOONSAENG , KIM YONG EUN , LEE JUN HEE , SHIN DONGKYU , KIM CHEOL MIN , HYUN YOUNG-LAN , LEE CHEOL SOON , CHO JOONG-MYUNG , RO SEONGGU
IPC分类号： C07D487/04 , A61K31/437 , A61P3/10 , A61P35/00
CPC分类号： C07D471/04
-
-
-
-
-
-
-
搜索结果
8 条记录 (耗时 0.009 秒)
